搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Pulmonaryhypertensionnews.com
4 天
MicroRNA in blood could be PAH marker in congenital heart disease
Significantly higher levels of the miRNA molecule miR-3591-5p were seen in those with CHD and moderate to severe PAH than ...
Pulmonaryhypertensionnews.com
6 天
Platelets get trapped in lungs in PH patients with heart failure: Study
Platelets tend to cluster in lung blood vessels in people with decompensated pulmonary hypertension, increasing their risk of ...
Pulmonaryhypertensionnews.com
8 天
When faced with a trying situation, my son tries harder
Columnist Colleen Steele's son Cullen has endured PAH, a heart-lung transplant, and loss, but each trying situation has ...
Pulmonaryhypertensionnews.com
12 天
Reproductive healthcare is a key part of my post-transplant regimen
Columnist Anna Jeter explains how reproductive healthcare was ingrained in both her PH treatment plan and her post-transplant ...
Pulmonaryhypertensionnews.com
6 天
There are so many things to be thankful for, even with PH
Managing chronic illness comes with many challenges, columnist Jen Cueva says, but there are still countless reasons to be thankful.
Pulmonaryhypertensionnews.com
8 天
Awareness campaign aims to improve PAH diagnosis, treatment
The American Lung Association launched an awareness campaign to accelerate diagnosis and improve treatment of PAH.
Pulmonaryhypertensionnews.com
14 天
Phase 2 trial of TX45 for PH-HFpEF beginning to enroll patients
Tectonic Therapeutic announced the global study is starting to recruit up to 180 adult patients; injections given every 2 ...
Pulmonaryhypertensionnews.com
12 天
Advocacy partners
Bionews, Inc., the parent company of this site, has partnered with the following nonprofit advocacy organizations to help further the mission of ensuring that patients and caregivers are able to get ...
Pulmonaryhypertensionnews.com
11 天
Cereno secures loan financing to continue developing CS1 for PAH
Cereno Scientific has secured loan financing to continue developing CS1, its lead therapeutic candidate for pulmonary arterial hypertension.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈